Boards of Directors
About the AAN
The AAN and AAN Institute Boards of Directors oversee the Academy’s achievement of its vision, mission, and goals through the prudent management of the business and corporate affairs of the Academy. The Boards perform the policymaking role of the organization by setting the strategic direction and providing oversight for the Academy’s finances and programs.
2023-2025 aan Board of Directors
Officers
Directors
Ex-Officio Directors
-
Bruce H. Cohen, MD, FAAN
Chair, Advocacy Committee/ex officio
-
Brad C. Klein, MD, MBA, FAAN
Chair, Medical Economics and Practice Committee/ex officio
-
José G. Merino, MD, MPhil, FAHA, FAAN
Editor-in-Chief of Neurology®/ex officio
-
Nimish A. Mohile, MD, FAAN
Chair, Diversity, Equity, and Inclusion Committee/ex officio
-
Maisha T. Robinson, MD, MSHPM, FAAN, FAAHPM
Chair, Member Engagement Committee/ex officio
-
Mary E. Post, MBA, CAE
Chief Executive Officer/ex officio, non-voting
The Academy is comprised of two legal entities, the AAN and the AAN Institute. Most of the elected members of the AAN Board of Directors also serve ex officio on the Board of Directors of the AAN Institute, which includes an independent secretary-treasurer and additional members who serve in ex officio capacities. The AAN Institute Board of Directors will include the following additional members:
AAN Institute Board of Directors
-
Brett M. Kissela, MD, MS, FAHA, FAAN
Secretary/Treasurer
-
Paul George, MD, PhD, FAAN
Chair, Science Committee/ex officio
-
Lyell K. Jones, Jr., MD, FAAN
Chair, Quality Committee/ex officio
-
José G. Merino, MD, MPhil, FAHA, FAAN
Editor-in-Chief of Neurology®/ ex officio
-
Joseph I. Sirven, MD, FAAN
Chair, Education Committee/ex officio